- Home
- FLL vs IBIO Comparison
FLL vs IBIO Comparison
Compare FLL & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLL | IBIO |
|---|---|---|
| Founded | 1987 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.9M | 52.8M |
| IPO Year | 2014 | 2009 |
Fundamental Metrics
Financial Performance| Metric | FLL | IBIO |
|---|---|---|
| Price | $0.53 | $0.72 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 9 |
| Target Price | $1.56 | ★ $5.69 |
| AVG Volume (30 Days) | 431.8K | ★ 470.8K |
| Earning Date | 11-05-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 3.45 | ★ 81.71 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $302,376,000.00 | N/A |
| Revenue This Year | $3.53 | N/A |
| Revenue Next Year | $4.48 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 3.53 | N/A |
| 52 Week Low | $0.56 | $0.69 |
| 52 Week High | $3.37 | $3.82 |
Technical Indicators
Market Signals| Indicator | FLL | IBIO |
|---|---|---|
| Relative Strength Index (RSI) | 23.82 | 37.52 |
| Support Level | N/A | $0.71 |
| Resistance Level | $1.19 | $0.85 |
| Average True Range (ATR) | 0.09 | 0.06 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 1.24 | 15.62 |
Price Performance
Historical ComparisonAbout FLL Full House Resorts Inc.
Full House Resorts Inc owns, operates, develops, manages, and invests in casinos and related hospitality and entertainment facilities. It offers facilities related to gaming, hotel, dining, entertainment, retail, and other amenities. The group's reportable segments are Midwest & South, West, and Contracted Sports Wagering, It generates the majority of its revenue from the Midwest & South segment which includes Silver Slipper Casino and Hotel, Rising Star Casino Resort, and American Place. The west segment includes Grand Lodge, Stockman's Casino, Bronco Billy's Casino and Hotel, and Chamonix Casino Hotel. The Contracted Sports Wagering segment comprises on-site and online sports wagering skins. Geographically, it operates in United States.
About IBIO iBio Inc.
iBio Inc is a clinical-stage biotechnology company using Artificial Intelligence (AI) for the development of hard-to-drug precision antibodies for obesity, cardiometabolic, and cardiopulmonary diseases. Its product candidate pipeline includes IBIO-610, a monoclonal antibody designed to block Activin E; IBIO-800, a bispecific antibody program targeting myostatin, growth differentiation factor 11 (GDF11), and Activin A; IBIO-600; Amylin Antibody; and Target 4, in different stages of development, being developed as potential therapies for obesity and cardiometabolic disease. The company operates as one reportable segment, which is that of a biotechnology company leveraging AI and ML for the development of hard-to-drug precision antibodies.